Tech Company Financing Transactions
Arctic Therapeutics Funding Round
Arctic Therapeutics, based in Reykjavik, raised $21.5 million from Kaldbakur ehf, Sanos Group and private investors.
Transaction Overview
Company Name
Announced On
10/21/2026
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Undisclosed
Investors
Kaldbakur ehf (Lead Investor)
Sanos Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its pipeline assets, AT-002 and AT-003, towards clinical development,while expanding its clinical pipeline beyond its lead programs (AT-001 and AT-004) in rare and common forms of dementia and inflammatory skin diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Gróska Innovation Center, Bjargargata 1
Reykjavik, 102
Iceland
Reykjavik, 102
Iceland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We apply bioinformatic approaches and AI to eliminate major risks associated with traditional drug development, as well as sharply reducing the enormous cost and time to bring effective treatments to millions of patients. We collaborate closely with The Center for Applied Genomics (CAG) at the Children's Hospital of Philadelphia (CHOP) to develop ground-breaking new medical treatments. We leverage over 20 years of genomics research, redefining and de-risking drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ívar Hákonarson
Browse more venture capital transactions:
Prev: 10/21/2026: Otter venture capital transaction
Next: 10/21/2026: Qualitate venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs